nafronyl has been researched along with Peripheral Arterial Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harnan, S; Meng, Y; Michaels, J; Simpson, E; Squires, H; Stansby, G; Stevens, J; Thomas, S; Wong, R | 1 |
| Harnan, S; Meng, Y; Michaels, J; O'Donnell, ME; Simpson, E; Squires, H; Stansby, G; Stevens, JW; Thomas, S | 1 |
1 review(s) available for nafronyl and Peripheral Arterial Diseases
| Article | Year |
|---|---|
A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
Topics: Cilostazol; Cost-Benefit Analysis; Humans; Intermittent Claudication; Nafronyl; Nicotinic Acids; Pentoxifylline; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Tetrazoles; United Kingdom; Vasodilator Agents | 2011 |
1 other study(ies) available for nafronyl and Peripheral Arterial Diseases
| Article | Year |
|---|---|
Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
Topics: Cilostazol; Cost-Benefit Analysis; Decision Support Techniques; Humans; Intermittent Claudication; Markov Chains; Nafronyl; Pentoxifylline; Peripheral Arterial Disease; Tetrazoles; Vasodilator Agents | 2014 |